Jean-Baptiste M.
- Country
- France
- Department
- Service Hematologie
Research Overview
- A multi-center randomized, double blinded phase IIb trial evaluating oral pooled fecal microbiotherapy MaaT033 to prevent allogeneic hematopoietic cell transplantation complications
- Evaluation of Oral Vancomycin for Prophylaxis of Clostridium difficile Infections in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation
- Evaluation of Belumosudil and Prednisone Versus Placebo and Prednisone in Patients Aged 12 and Older with Newly Diagnosed Chronic Graft-Versus-Host Disease
Data & Insights
Has run more than one trial at 85 of 191 partner sites.
Specializations
Leukemia Treatment
Specializes in developing innovative therapies for acute myeloid leukemia (AML) and B-cell acute lymphoblastic leukemia. Focuses on targeted treatments, particularly for patients with specific genetic alterations and those with relapsed or refractory disease.
- Novel therapeutic approaches for AML
- B-ALL treatment strategies
- Genetic mutation-specific therapies
Transplant Medicine
Conducts research in allogeneic hematopoietic stem cell transplantation, investigating conditioning regimens and post-transplant complications. Explores innovative approaches to improve transplant outcomes and reduce associated risks.
- Reduced intensity conditioning protocols
- Infection prevention strategies
- Microbiome therapeutics in transplantation
Graft-versus-Host Disease
Expert in treating both acute and chronic graft-versus-host disease, with particular focus on novel therapeutic combinations and early intervention strategies. Investigates innovative immunomodulatory approaches for better disease management.
- Novel GVHD treatments
- Corticosteroid combination therapies
- Early intervention protocols
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.